Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases

Atef Hammad Teama; Kamal Mohamed Okasha; Sameh Ahmed Khodair; Rehab Mohamed EL-Nagar

doi:doi:10.11648/j.ijmi.20150306.13

| Peer-Reviewed

Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases

Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar

Published in International Journal of Medical Imaging (Volume 3, Issue 6)

Received: 23 October 2015 Accepted: 3 November 2015 Published: 19 November 2015

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.

Published in	International Journal of Medical Imaging (Volume 3, Issue 6)
DOI	10.11648/j.ijmi.20150306.13
Page(s)	114-129
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Ultrasound Guided, Renal Biopsy, CT Guided, Renal Parenchymal Disease

References

[1]	Stevens PE, O'Donoghue DJ, de LS et al. Chronic kidney disease management in the UnitedKingdom: NEOERICA project results. Kidney Int 2007; 72(1): 92-99.
[2]	Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41(1): 1-12.
[3]	Barsoum RS. End-stage renal disease in North Africa. Kidney Int Suppl 2003; (83): S111-S114.
[4]	Fiorini F, Barozzi L. The role of ultrasonography in the study of medical nephropathy. Journal of Ultrasound 2007; 10(4): 161-167.
[5]	Buturovi-ç-Ponikvar J, Visnar-Perovic A. Ultrasonography in chronic renal failure. Eur J Radiol 2003; 46(2): 115-122.
[6]	Alebiosu CO, Kadiri S. Percutaneous renal biopsy as an outpatient procedure. J Natl Med Assoc 2004; 96(9): 1215-1218.
[7]	Salama AD. Renal biopsy. Medicine 2011; 39(6): 339-342.
[8]	Uppot RN, Harisinghani MG, Gervais DA. Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 2010; 194(6): 1443-1449.
[9]	Garg AK, Kanitkar M, Venkateshwar V. Clinicopathological spectrum of renal biopsies in children. Medical Journal Armed Forces India 2010; 66(3): 216-219.
[10]	Riccabona M, Mache C, Ring E. Renal Parenchymal Disease. In: Fotter R, editor. Pediatric Uroradiology.Berlin, Heidelberg: Springer; 2008. 355-383
[11]	Waldo B, Korbet SM, Freimanis MG, Lewis EJ. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrology Dialysis Transplantation 2009; 24(8): 2433-2439.
[12]	Atwell TD, Smith RL, Hesley GK et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol 2010; 194(3): 784-789.
[13]	Chan KW, Chan TM, Cheng IK. Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review. Hong Kong Med J 1999; 5(3): 240-244.
[14]	Rahbar M. Kidney biopsy in west of Iran: Complications and histopathological findings. Indian J Nephrol 2009; 19(2): 68-70.
[15]	Francis M, Barsoum R. Spectrum of Glomerulonephritis in Egypt. Saudi J Kidney Dis Transpl 2000; 11(3): 421-429.
[16]	Al Arrayed A, George SM, Malik AK et al. The spectrum of glomerular diseases in the kingdom of bahrain: An epidemiological study based on renal biopsy interpretation. Transplantation proceedings 2004; 36(6): 1792-1795.
[17]	Shawarby M, Al Tamimi D, Al Mueilo S et al. A Clinicopathologic Study of Glomerular Disease: Experience of the King Fahd Hospital of the University, Eastern Province, Saudi Arabia. Hong Kong Journal of Nephrology 2010; 12(1): 20-30.
[18]	Ossareh S, Asgari M, Abdi E et al. Renal biopsy findings in Iran: case series report from a referral kidney center. Int Urol Nephrol 2010; 42(4): 1031-1040.
[19]	Tang S, Li JH, Lui SL, Chan TM, Cheng IK, Lai KN. Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur J Radiol 2002; 41(1): 65-69.
[20]	Torres MA, Valdez-Ortiz R, Gonzalez-Parra C et al. Percutaneous renal biopsy of native kidneys: Effeciency, saftey, & risk factors associated with major complications. Arch Med Sci 2011; 7 (5): 823-831.
[21]	Sugiyama H, Yokoyama H, Sato H et al. Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 2011; 15(4): 493-503.
[22]	Burstein DM, Korbet SM, Schwartz MM. The use of the automatic core biopsy system in percutaneous renal biopsies: a comparative study. Am J Kidney Dis 1993; 22(4): 545-552.
[23]	Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988; 8(2): 85-89.
[24]	Castro R, Sequeira MJ, Sameiro FM et al. Percutaneous kidney biopsy: eight years-experience. Acta Med Port 2004; 17(1): 20-26.
[25]	Gonzalez-Michaca L, Chew-Wong A, Soltero L, Gamba G, Correa-Rotter R. Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment. Rev Invest Clin 2000; 52(2): 125-131.
[26]	Mishra A, Tarsin R, Elhabbash B et al. Percutaneous ultrasound-guided renal biopsy. Saudi J Kidney Dis Transpl 2011; 22(4): 746-750.
[27]	Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15(1): 142-147.
[28]	Manno C, Strippoli GF, Arnesano L et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66(4): 1570-1577.
[29]	Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005; 9(1): 40-45.
[30]	Bach D, Wirth C, Schott G, Hollenbeck M, Grabensee B. Percutaneous renal biopsy: three years of experience with the biopty gun in 761 cases--a survey of results and complications. Int Urol Nephrol 1999; 31(1): 15-22.
[31]	Simckes AM, Blowey DL, Gyves KM, Alon US. Success and safety of same-day kidney biopsy in children and adolescents. Pediatr Nephrol 2000; 14(10-11): 946-952.
[32]	Moghazi S, Jones E, Schroepple J et al. Correlation of renal histopathology with sonographic findings. Kidney Int 2005; 67(4): 1515-1520.
[33]	Rosenfield AT, Siegel NJ. Renal parenchymal disease: histopathologic-sonographic correlation. American Journal of Roentgenology 1981; 137(4): 793-798.

Cite This Article

Plain Text BibTeX RIS

APA Style

Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. (2015). Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. International Journal of Medical Imaging, 3(6), 114-129. https://doi.org/10.11648/j.ijmi.20150306.13

Copy | Download

ACS Style

Atef Hammad Teama; Kamal Mohamed Okasha; Sameh Ahmed Khodair; Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int. J. Med. Imaging 2015, 3(6), 114-129. doi: 10.11648/j.ijmi.20150306.13

Copy | Download

AMA Style

Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int J Med Imaging. 2015;3(6):114-129. doi: 10.11648/j.ijmi.20150306.13

Copy | Download

@article{10.11648/j.ijmi.20150306.13,
  author = {Atef Hammad Teama and Kamal Mohamed Okasha and Sameh Ahmed Khodair and Rehab Mohamed EL-Nagar},
  title = {Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases},
  journal = {International Journal of Medical Imaging},
  volume = {3},
  number = {6},
  pages = {114-129},
  doi = {10.11648/j.ijmi.20150306.13},
  url = {https://doi.org/10.11648/j.ijmi.20150306.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20150306.13},
  abstract = {Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases
AU  - Atef Hammad Teama
AU  - Kamal Mohamed Okasha
AU  - Sameh Ahmed Khodair
AU  - Rehab Mohamed EL-Nagar
Y1  - 2015/11/19
PY  - 2015
N1  - https://doi.org/10.11648/j.ijmi.20150306.13
DO  - 10.11648/j.ijmi.20150306.13
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 114
EP  - 129
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20150306.13
AB  - Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.
VL  - 3
IS  - 6
ER  -

Copy | Download

Author Information

Atef Hammad Teama

Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, Tanta, Egypt
Kamal Mohamed Okasha

Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
Sameh Ahmed Khodair

Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, Tanta, Egypt
Rehab Mohamed EL-Nagar

Radiodiagnosis & Medical Imaging Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. (2015). Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. International Journal of Medical Imaging, 3(6), 114-129. https://doi.org/10.11648/j.ijmi.20150306.13

Copy | Download

ACS Style

Atef Hammad Teama; Kamal Mohamed Okasha; Sameh Ahmed Khodair; Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int. J. Med. Imaging 2015, 3(6), 114-129. doi: 10.11648/j.ijmi.20150306.13

Copy | Download

AMA Style

Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int J Med Imaging. 2015;3(6):114-129. doi: 10.11648/j.ijmi.20150306.13

Copy | Download

@article{10.11648/j.ijmi.20150306.13,
  author = {Atef Hammad Teama and Kamal Mohamed Okasha and Sameh Ahmed Khodair and Rehab Mohamed EL-Nagar},
  title = {Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases},
  journal = {International Journal of Medical Imaging},
  volume = {3},
  number = {6},
  pages = {114-129},
  doi = {10.11648/j.ijmi.20150306.13},
  url = {https://doi.org/10.11648/j.ijmi.20150306.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20150306.13},
  abstract = {Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases
AU  - Atef Hammad Teama
AU  - Kamal Mohamed Okasha
AU  - Sameh Ahmed Khodair
AU  - Rehab Mohamed EL-Nagar
Y1  - 2015/11/19
PY  - 2015
N1  - https://doi.org/10.11648/j.ijmi.20150306.13
DO  - 10.11648/j.ijmi.20150306.13
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 114
EP  - 129
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20150306.13
AB  - Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.
VL  - 3
IS  - 6
ER  -

Copy | Download